Tg Therapeutics, Inc. (TGTX)

CIK 1001316 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tg Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 20261440001959173-26-006866
Aug 7, 202640001437749-26-026608
Aug 5, 202610-Q0001437749-26-025955
Aug 3, 20268-K0001437749-26-025304
Jun 15, 202640001437749-26-020677
Jun 15, 202640001437749-26-020676
Jun 15, 202640001437749-26-020675
Jun 15, 202640001437749-26-020673
Jun 15, 202640001437749-26-020679
Jun 12, 20268-K0001437749-26-020491
Jun 3, 20268-K0001437749-26-019262
May 27, 20268-K0001437749-26-018586
May 6, 20268-K0001437749-26-015013
May 6, 202610-Q0001437749-26-015246
Apr 30, 2026DEF 14A0001437749-26-014233
Apr 29, 2026SCHEDULE 13G0002100121-26-000832
Mar 27, 2026SCHEDULE 13G/A0000102909-26-002442
Mar 20, 20268-K0001437749-26-009253
Feb 27, 202610-K0001437749-26-006133
Feb 26, 20268-K0001437749-26-005733
Jan 29, 202640001437749-26-002439
Jan 13, 20268-K0001437749-26-001194
Jan 9, 202640001437749-26-001015
Jan 9, 202640001437749-26-001016
Nov 25, 202540001437749-25-036358